Clinical Trial Update: A Prospective, Single-Arm, Multicenter, Phase II Clinical Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer With Acquired Resistance to Immunotherapy and High YAP Protein Expression [Phase 2]

View source ↗

Summary

A Phase II, prospective, single-arm multicenter trial evaluating chidamide in combination with ivonescimab for advanced non-small cell lung cancer with immunoth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Chidamide (chidamide)
• Ivonescimab (AK112/SMT112)

Snippet

Sponsor: Guangdong Association of Clinical Trials | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING